000 01062 a2200265 4500
005 20250515032142.0
264 0 _c20061114
008 200611s 0 0 eng d
022 _a0011-9059
024 7 _a10.1111/j.1365-4632.2006.02720.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBurkhart, Craig G
245 0 0 _aMesalamine may be preferable to sulfasalazine in dermatologic therapeutics.
_h[electronic resource]
260 _bInternational journal of dermatology
_cJun 2006
300 _a779-80; author reply 780 p.
_bdigital
500 _aPublication Type: Comment; Comparative Study; Letter
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLichen Planus
650 0 4 _aMesalamine
_xtherapeutic use
650 0 4 _aSulfasalazine
_xtherapeutic use
650 0 4 _aTreatment Outcome
773 0 _tInternational journal of dermatology
_gvol. 45
_gno. 6
_gp. 779-80; author reply 780
856 4 0 _uhttps://doi.org/10.1111/j.1365-4632.2006.02720.x
_zAvailable from publisher's website
999 _c16390068
_d16390068